Key Parkinson’s protein could offer new potential targets for treatment
The findings could lead to new treatments to target the mTOR and ease PD symptoms
Read More
Tag: mammalian target of rapamycin
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
